Only a minority of the many genomic clusters of transcription factor binding motifs (TFBM) 21 act as transcriptional enhancers. To identify determinants of enhancer activity, we randomized 22 the spacer sequences separating the ETS and GATA sites of the early neural enhancer of the 23 tunicate Ciona intestinalis Otx gene. We show that spacer sequence randomization affects the 24 level of activity of the enhancer, in part through distal effects on the affinity of the 25 transcription factors for their binding sites. A possible mechanism is suggested by the 26 observation that the shape of the DNA helix within the TFBM can be affected by mutation of 27 flanking bases that modulate transcription factor affinity. Strikingly, dormant genomic 28 clusters of ETS and GATA sites are awakened by most instances of spacer randomization, 29
INTRODUCTION 37
Enhancers play a fundamental role in development, homeostasis, evolution and disease (1, 2) . 38
They act as scaffolding platforms for transcription factors and are generally composed of 39 clusters of several binding sites for at least two transcription factors (3). The degree of 40 constraints on the spacing, order and orientation of transcription factor binding sites is 41 variable, with a majority of enhancers active during animal development showing little 42 constraints (4). In spite of this apparent flexibility, we do not understand the determinants of 43 enhancer activity and it remains very difficult to rationally engineer synthetic enhancers from 44 the sole knowledge of upstream transcription factor binding sites (5). 45
RESULTS 72

Contribution of the bases contacted by Transcription Factors to enhancer activity 73 74
Our aim was to determine the respective roles of transcription factor binding sites and spacer 75 sequences in a-element enhancer activity. For the sake of simplification, we used an a-76 element variant in which the G2 site was inactivated by point mutation, as this site was shown 77
to be dispensable for enhancer activity ( Figure 1C ; 8). We first analysed the influence of the 78 stretch of DNA directly contacted by Ets1/2 and Gata4/5/6 on the in vivo enhancer activity of 79 the a-element. Published crystal structures for mammalian homologs bound to DNA 80 (Supplementary Figure 1) suggest that Gata4/5/6 directly contacts 6 nucleotides: a central 81 "GATA" core motif flanked on either side by one nucleotide (14, 15, 16). The contacts 82 established by Ets1/2 span 7 nucleotides centered on GGA (17, 18, 19) . To assess the relative 83 importance of the nucleotides flanking the invariant "GGA" core of E2 and the "GATA" core 84 of G3 ( Figure 1C ) we compared the activity of several combinations of point mutations by 85 scoring LacZ staining in the a6.5 and b6.5 lineages in 112-cell stage embryos electroporated 86 with reporter constructs (Figure 1D , E; see material and methods). 87
As expected, changes in the sequences of E2 and G3 quantitatively affected activity levels of 88 the a-element in a6.5 and/or b6.5 lineages, while qualitatively preserving its spatial pattern of 89 activity (not shown). In response to alteration of either binding site, the output levels of 90 variant enhancers ranged from an almost complete inactivity to stronger than WT levels 91 Consistently, out of 14 genomic clusters of 2 ETS and 2 GATA sites with in silico predicted 105 affinity scores for their cognate factor at least as good as the a-element, only two, N83 and 106 Table 1 As neither the arrangement (8) nor the sequences of transcription factor recognition sites fully 132 explain enhancer activity, we next tested whether the stretches of nucleotides located between 133 transcription factor binding sites, subsequently called spacers, affect enhancer activity. We 134 constructed a library of synthetic enhancers: each randomized variant shared with the a-135 element the six bases centered on the "GATA" and "GGAA" core sequences of the four 136 GATA-and ETS-binding sites, respectively, as well as the orientation and spacing of these 137 sites. All spacer sequences were, however, fully randomized, the four bases being 138 equiprobable at each position. The in vivo enhancer activity of 34 randomized a-elements 139 (Supplementary Figure 6A; Supplementary Table 2 ) was determined by electroporation as 140
N26, behaved as enhancers (Supplementary
above. 141
While a large majority of naturally occurring genomic clusters of putative ETS and GATA 142 sites are inactive, 25 out of 34 randomized a-element variants had an activity higher or equal 143 to 10% of the wild-type activity, and were considered active (Figure 2 ). These enhancers 144 displayed a wide range of activity levels with 11 of the variants being at least as active as the 145 original a-element. Spacers are thus quantitative regulators of enhancer activity. The activity 146 of these variants was mostly restricted to a6.5 and b6.5 lineages. In addition, most variants 147 with higher activity than the WT enhancer, as well as three variants with lower activity, 148
showed weak activity in other cell lineages, in which the a-element is weakly active, mainly 149 neural plate and muscle cells ( A) The sequence of the a-element with randomized bases represented by N and the conserved 161 GATA motifs boxed in green and ETS motifs in blue, the arrow pointing to their orientation . 162 B) In vivo enhancer activity for 34 randomized variants normalized by the wild type enhancer 163 activity in matching experiment. At least two independent experiments are shown for each 164 construct. Blue bars correspond to exclusive expression in a6.5 and b6.5 lineages, red bars to 165 additional expression in a6.7, B6.4 and other lineages.
167
Randomized a-element variants with low in vivo activity have decreased in vitro affinity 168 for Ets1/2 and Gata4/5/6 compared to high activity variants 169
170
To assess the influence of spacer sequences on the binding of Ets1/2 and Gata4/5/6 to the a-171 element we turned to in vitro binding experiments. We selected 9 randomized variants with 172 equal or higher activity levels than the a-element and 9 variants with undetectable or very low 173 activity ( Figure 3A ). Using the QuMFRA assay (21), we determined the relative in vitro 174 binding affinities of the transcription factors for each of the complete enhancer variants 175 (Supplementary Figure 4) . Active variants showed significantly higher in vitro binding for the 176 combination of Ets1/2 and Gata4/5/6 proteins than low activity variants (paired t-test, 177 p=0.001) ( Figure 3B ). Both Ets1/2 and Gata4/5/6 proteins individually contributed to the 178 binding preference for active enhancers, with a significantly higher contribution for Ets1/2 179 (paired t-test, p-value of 0.02327 for Ets1/2 compared to 0.05347 for Gata4/5/6; 180
Supplementary Figure 9B We then analysed the individual sites in more detail in order to better understand the spacer 199 effect on transcription factor affinity. Farley and colleagues proposed that the activity of the enhancers is primarily determined by 209 the two bases flanking each side of the "GGAA" or "GATA" core motif sequences (9). We 210 note, however, that in our experiments active variant aR_30 and inactive variant aR_70 share 211 very similar 8 bp-extended ETS and GATA sites, suggesting that additional bases of the 212 spacers contribute to the spacer effect on affinity (Supplementary Figure 6A) . To differentiate 213 the effects of proximal bases immediately flanking the transcription factor binding sites to 214 that of more distal effects, we focused on ETS sites, since the ETS sites displayed the most 215 variable affinities. 216
We first tested a 10 bp binding site by keeping 10 bp of the randomized variants centered on 217 the 6 bp core and completing the fragment with wild type flanking sequences to obtain a 30-218 mer (see oligonucleotide aRn-E1/E2s in Figure 4A ). Ets1/2 demonstrated very different 219 affinities for individual variants ( Figure 4B ). Importantly, sites with identical core octamers 220 showed different affinities. For instance, the core octamer "TAGGAAAT" is present in both 221 the high affinity aR9_E2 and the low affinity aR30_E2 sites, while the core "GCGGAAGG" 222 is present in both the high affinity aR19_E1 and the low affinity aR5_E1 and aR43_E1 sites 223 (Supplementary table 3) . Thus, the observed affinities cannot be explained by the core 224 octamer only, although the protein is not known to contact bases beyond this motif. the presence of a purine at -1 leads to a negative roll between base pairs -1 and 1 as 268 determined by DNA shape modelling, the roll representing the angle between two consecutive 269 base pairs ( Figure 5B) (21) . All the high affinity tested sites had a negative roll, while the low 270 affinity sites had a more variable distribution ( Figure 5C ). Thus, spacer sequences flanking 271 the transcription factor binding site can modify the shape of the DNA helix at the 272 transcription factor binding site, which may alter the affinity of Ets1/2 binding. 273
274
More distal spacer sequences also affect the affinity of Ets1/2 binding 275
To assess whether the decamer bridging bp -1 and 9 is sufficient to explain the observed 277 affinities or whether the more distally sequences can also contribute, we compared the in vitro 278 affinities of the variant decamer ETS sites in the wild-type context (aRn-E1/E2s) to that of the 279 complete variant 30-mer fragments (aRn-E1/E2l in Supplementary Figure 12) . Indeed, further 280 addition of spacer sequences at both sites of the decamer modifies the affinity of 5 of the 7 281 tested ETS binding sites (Supplementary Figure 12) . 282
To analyze the relative roles of proximal and distal spacer sequences on transcription factor 283 affinity, we replaced the E1 site decamer of the inactive aR5 variant by that of the active aR19 To test whether the major effect of spacer sequences on enhancer activity levels was a 307 specific feature of the very compact a-element, we randomized the spacer sequences of a 308 larger active genomic ETS and GATA cluster, N26 (Supplementary Table 2 ), whose sites 309 spacing and orientation also differ from the a-element (Supplementary Figure 6B) . Similar 310 results (9/13 variants active in the neural lineages) were obtained with N26, suggesting that 311 the contribution of spacer sequences to enhancer activity is not a specific property of the 312 compact a-element ( Figure 7A) . 313
Most naturally occurring genomic clusters of ETS and GATA sites are transcriptionally 314 inactive. To assess whether this inactivity could be due to inappropriate spacer sequences, we 315 tested the effect of randomizing the spacers of two inactive genomic clusters. One, N61, has 316 naturally occurring high scoring in silico recognition sequences for both factors. The second, 317 C53 Opt, results from the optimization of the transcription factor binding sites of an inactive 318 cluster C53. C53 Opt has itself no activity (8). Strikingly, spacer randomization conferred 319 early neural enhancer activity to most variants of the two clusters (5/10 and 9/9 variants 320 respectively) (Figure 7B, C; supplementary figure 6 C, D) . We conclude that the inactivity of 321 the tested genomic ETS and GATA clusters is due to inappropriate spacer sequences and that, 322 sequences for the two ETS and three GATA sites unchanged. The randomization thus affected 377 both bases directly contacted by the transcription factors and directly flanking the core 378 nucleotides, and the spacers as defined in our study. This strategy was therefore able to pick 379 up both determinants of TFBM affinity to their transcription factors, which were the main 380 interest of the authors, and spacer features. A closer analysis of their data indicates that sub-381 selections of their synthetic enhancers containing binding sites whose predicted in silico 382 affinity for ETS and GATA is above a certain threshold, contain both active and inactive 383 clusters with a wide range of activity levels. Thus, their data are consistent with a role for 384 spacer sequences in setting enhancer activity levels. 385
In mammals, few studies involved the systematic large-scale analysis of enhancer variants. In 386 most cases single point mutations were tested, and the resulting effects are expected to be less 387 severe than the randomization approach described here and by Farley et al. (9) . Evidence 388 however also exists for a role of spacer sequences in enhancer activity. Kwasnieski fertilized and dechorionated as previously described (6). 480
Electroporation was performed as previously described (6) using the following parameters: site that could interfere with the ETS site activity and make the interpretation of the results 526 not straightforward. 527
Oligonucleotides were synthesized containing part of Gateway attB1 and attB2 recombination 528 sites in 5' and 3' respectively of the different elements we tested. These oligonucleotides were 529 amplified by PCR using attB1F and attB2R primers, then inserted by successive BP and LR 530 reactions in pDONOR221_P1-P2 and pDEST-L1-RFA-L2-bpFOG-LacZ (43). 531
532
Randomized variants 533 534
Only six bases per transcription factor binding sites, centered on "GGAA" and "GATA" for 535 ETS and GATA respectively, were kept constant for the a-element variants. 7 bases were kept 536 constant for ETS in randomized N26, N61 and C53 clusters, as it appeared that the 1 st base of 537 the ETS site is important for in vitro binding. 538
Two nested PCRs were done to amplify the 5' end of the insert containing an attB1 site, the 539 sequence studied for its enhancer activity and the 5' end of bpFOG using primers attB1F and 540 P5 R first, then attB1 and P4 R. Three nested PCRs were performed to amplify the 3' end of 541 the insert containing the other half of bpFOG, the barcode and an attB2 site, using primers P1 542 F and attB2 R first, then P2 F and attB2 R then P3 F and attB2 R. Both fragments were 543 assembled in a last PCR using attB1 F and attB2 R. They were then inserted in pDEST-L1- regions of the oligonucleotides contained a barcode, which was unique to each experiment 556 and was used to multiplex oligonucleotide sequencing. The barcode included 6 bp 5' of the 557 randomized portion and 2-3 bp after the randomized region. Protein/DNA complexes were 558 selected by chromatography on a Ni+-NTA sepharose (GE Healthcare) column recognizing 559 the histidine tag. Bound oligonucleotides were then amplified by PCR using the constant ends 560 of each oligonucleotide. The binding/chromatography/amplification steps were repeated for 3-561 7 cycles. After each cycle, the selected oligonucleotides were pooled and sequenced using 562 Illumina Genome Analyzer IIx or HiSeq 2000 sequencer. Raw sequencing data were binned 563 according to barcodes and used for further analyses. Unprocessed raw sequence data are 564 available from the NCBI Short Reads Archive (SRA) (Accession XXXXXX). Before 565 analysing the dataset, the constant region ends with the bar code were removed, leaving just 566 the random portion of 20 bases. Duplicate oligonucleotides were removed from this set as 567 they are most likely artefacts of the PCR amplification. 568
569
In silico transcription factor binding site affinity prediction using MOTIF 570
571
We developed a software, called MOTIF, to estimate in silico the binding affinity of a 572 transcription factor to a DNA sequence, based on SELEX-seq data (also called HT-SELEX), 573
represented by the enrichment values of all 4096 6-mers present in the variable portion of the 574 sequenced oligonucleotides bound to the transcription factor in the HT-selex procedure. The 575 algorithm is as follows. 576
In a random set of oligonucleotides, k-mer frequencies will be distributed uniformly. HT-577 SELEX oligonucleotides are not random, as the method enriches for oligonucleotides bound 578 to the transcription factor. The k-mer frequency distribution will thus become skewed, and the 579 DNA-binding specificity of the transcription factor can be represented by an enrichment value 580 for each of the k-mers considered. 6-mers were used here since 4,096 k-mers provides a 581 sufficient number of k-mers without becoming sparse considering the depth of the 582 sequencing. k-mer frequencies are determined by counting the occurrences of each k-mer in 583 the set of unique oligonucleotides. To obtain an enrichment value, the observed count of each 584 k-mer in the sequenced oligonucleotides, obs, are normalized using the expected count, exp, 585 of each k-mer based on the number of sequenced oligonucleotides, n, with a variable 586 oligonucleotide length of d, as shown in equation 1 . 587
The enrichment score, e, was calculated as shown in equation 2. 589 (2). 590
591
The synthesis method used to produce the original random pool of oligonucleotides is often 592 biased, enriching certain k-mers over others. To correct for this bias, the enrichments are 593 adjusted by the enrichment in the background set, shown in equation 3. 594 Many transcription factors recognize motifs longer than 6 bases. MOTIF thus associate to 596 each base of the analysed DNA sequence a score predicting the binding of a transcription 597 factor to the 8-mer starting at this base (Supplementary Figure 2) . It corresponds to the sum of 598 the 6-mer enrichments scores of the three 6-mers contained in each 8-mers. 599 600
Selection of the14 ETS/GATA genomic clusters tested in vivo by electroporation 601 602
101 clusters containing at least 2 sites ETS and 2 sites GATA were identified in Ciona 603 intestinalis genome, using SECOMOD, and a very relaxed consensus for the transcription 604 factor binding sites sequences (as described in 8). We then looked for clusters of maximum 605 140 bp with at least 5 bp between two consecutive transcription factor binding sites. 55 606 conserved clusters were identified by (8). We tested the activity of an additional eight non-607 conserved and six conserved clusters in C. savignyi. 608
The 14 tested clusters contain 2 ETS and GATA sites with high MOTIF scores. Their 609 sequences are listed in Supp. Table 1 . 610 611
2-colour Fluorescent Electrophoretic Mobility Shift Assay 612 613
The DNA-binding domains of Ets1/2 (Ensembl ID: ENSCINT00000011848), i.e. aa 581-708, 614 and GATA4/5/6 (Ensembl ID: ENSCINP00000009159), i.e. aa 291-415, were identified by 615 homology to domains of orthologous human proteins used in the crystallographic 3D 616 structure determination (Ets1, MMDB ID: 62790 and GATA1, MMDB ID: 106606). The 617 corresponding DNA sequences were amplified by PCR from the cDNAs (44) and cloned in 618 the expression vector pETG20A (EMBL Protein Expression and Purification Facility) by 619
Gateway technology (Life Sciences). N-terminally poly-His-thioredoxin tagged recombinant 620 proteins were produced in Rosetta-pLys-R strain and purified on Nickel Agarose columns as 621 described in (45). 622
Enhancer DNA fragments were produced by PCR from the plasmids used for the LacZ 623 reporter assays using Cy5 or Alexia 488-5' labelled 19 nt primers (MWG Eurofins) flanking 624 the enhancer sequences, i.e. TTGTACAAAAAAGCAGGCT for the forward and 625
GGTACAATACACGAAGCTT for the reverse primer. DNA fragments containing unique 626 transcription factor binding sites were synthesized directly (MWG Eurofins) and 5'-terminally 627 labelled with Cy5 or Cy3 for the internal control on one strand. 628
The reaction conditions for the GS experiments were adapted from Hashimoto & Ware, 629 (1995). Labelled DNA was incubated at 0.015 µM with recombinant Ets1/2 at 0.2 µM or 630
Gata4/5/6 at 0.1 µM during 15 minutes at room temperature in 25mM Hepes pH7.9, 50mM 631 KCl, 0.5 mM EDTA, 10% glycerol, 0.5mM di-thiothreitol and 100 µg/ml poly(dI-dC) and 632 loaded on a 6% polyacrylamide gel in 0.5 % TAE, which was run at 10V/cm. The 633 fluorescence was registered with an Amersham Imager 600 (General Electric) and quantified 634 with the software provided by the supplier. 635
To have a better control over the experimental conditions we included an internal control: the 636 randomized DNA fragments are fluorescently labelled with Cy5 and mixed with an equimolar 637 amount of control DNA fragment labelled with Alexia 488 or Cy3. Relative affinities Y are 638 quantified by reporting the fraction of shifted randomized DNA fragments to that of control 639 fragment (21) (Supplementary Figure 4) . 640
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